|
|
|
|
|
by thaumasiotes
1631 days ago
|
|
> Its lunacy for tests to be regulated beyond requiring rough false positive false negative rates There is a good reason tests are described in terms of sensitivity and specificity ("if the answer in reality is yes, how often will the test say no?") rather than in terms of false positive or false negative rates ("if the test says no, how often is the true answer yes?"). The sensitivity and specificity are facts about the test which can conceptually stay constant[1] as you apply the test to different people. False positive and false negative rates do not have that property; they are facts about the group you're performing tests on just as much as they're facts about the test. [1] This is not to say that the sensitivity and specificity of a test do stay constant as you apply the test to different populations. Often they won't. But it is a theoretical possibility, and even that isn't true for false negative rates. |
|
This is is not a legal problem, its a customer experience one, and as such its very much what the free market does well. A clever company could say that the tests service we provide works in a two stage process where a preliminary test is used to identify which conditions need to be investigated further, the results of which are presented in a meeting with one of our doctors were the results are explained and additional tests are performed to resolve any ambiguity. This combines the benefits of sensitivity, and specificity in a resource efficient way, and does not provide the user with any scary results before a certain answer is available. The FP,FN,TP,TN probabilities for gen pop for such a company would be much better than those of companies trying to do so in a single pass. But for these figures to mean anything regulating that they are available and reasonably accurate is key to ensure an efficient market.
Another problem is of course that the tests themselves are shit, or the rates based on poor data. The requirement on reasonably accurately reported gen pop rates help with this however, and I see no way around legally forcing diagnostic services providers to prove this. And until someone does, my patent pending algorithm(){return false} tests for all rare genetic disorders with excellent accuracy^^